Hospice Tlc, Inc Medicare Approved Location: 2401 Loop Road, Winnsboro, Louisiana 71295 Phone: (318) 435-9111 |
News Archive
The case of a mother and her autistic son who were removed from a flight in the United States serves to highlight the problems faced by carers of those with behavioural disorders as well as the plight of organisations catering for the general public.
UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.
Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").
"Polio has reappeared in a corner of the world that had not seen cases in years - Tajikistan, the former Soviet republic - a chilling setback in the two-decade campaign to purge a dreaded cause of childhood paralysis from the planet," the Boston Globe reports in a story that examines the reemergence of polio in other areas of the world.
› Verified 1 days ago